Krsnaa Diagnostics earnings calls.
Other · 2 quarters tracked · source-linked performance, management guidance and promise context.
Latest revenue
₹193 Cr
verified financial record
Quarters tracked
2
source records in the directory
Delivery assessment
0
Across 2 tracked commitments: 0 delivered, 2 missed.
Call date
Pending
latest available source date
Signal trajectory
2 actual quartersCurrent read
0/100
Across 2 tracked commitments: 0 delivered, 2 missed.
Latest source read
What changed this quarter?
Krsnaa Diagnostics reported steady Q1 FY26 results with ₹193 crore revenue (+13% YoY) and ₹52.4 crore EBITDA (+19% YoY), delivering 120bps margin expansion to 27%. ₹20.5 crore PAT (+15% YoY) demonstrates bottom-line momentum. The flagship Rajasthan PPP contract (42 mother labs, 135 satellite labs, 1,300+ collection centers) represents a transformative ₹300-350 crore annualized revenue opportunity with ₹200-250 crore capex, ramping over 6-9 months with full revenues from FY27. Retail expansion continues accelerating with 24,414 touchpoints (+7x YoY) contributing 6% to group revenues, targeting 5-8% by FY26 and 18-20% over two years. Maharashtra radiology rollout (73 CT/MRI centers) is 75% complete by Q3 FY26. Volume growth was subdued at 4% due to prior BMC contract exit and project suspensions, though management expects improvement. Karnataka revenue faced procedural headwinds but Himachal Pradesh remained stable. Working capital improved with overdue payments received from HP and Karnataka. EBITDA break-even for retail targeted by FY26 end.
Colored figures compare against the previous available record. Hover or focus one for the comparison.
Signal
Watch
Revenue
₹193 Cr
Source date
Pending
Across the record
Quarter history.
History modules